U.S. IPO Weekly Recap: A Quiet Week Ahead Of 2018's Final Stretch

|
Includes: MRNA
by: Renaissance Capital IPO Research

No companies went public this past week, during the post-Thanksgiving lull.

Three healthcare deals joined the IPO calendar for next week. Messenger RNA developer Moderna (NASDAQ:MRNA) is the week's largest offering, aiming to raise $500 million in the biggest biotech IPO ever.

There were no new IPO filings, aside from two SPACs. Blank check company Andina Acquisition III (ANDAU) filed to raise $100 million to acquire a business in Latin America, while Chardan Healthcare Acquisition (CHACU) filed to raise $70 million as it explores a healthcare business to acquire. Therefore, what is currently in the IPO pipeline is what can go public in 2018; others will have to wait.

The IPO Index climbed 4.0% this past week, though it is still well below its level before the sell-off that began in October.

2 SPAC Filings During the Week of November 26th, 2018

Issuer
Business

Deal
Size

Sector

Lead
Underwriter

Andina Acquisition III (ANDAU)

$100M

SPAC

Cowen

Blank check company formed to acquire a business in Latin America.

Chardan Healthcare Acq. (CHACU)

$70M

SPAC

Chardan

Blank check company formed by Chardan to acquire a healthcare business.

Editor's Note: This article covers one or more microcap stocks. Please be aware of the risks associated with these stocks.